{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:57:34Z","timestamp":1782543454304,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2700500"],"award-info":[{"award-number":["2021YFC2700500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2700500"],"award-info":[{"award-number":["2021YFC2700500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Technology and Innovation Commission of Shenzhen Municipality","award":["JCYJ20200109140623124"],"award-info":[{"award-number":["JCYJ20200109140623124"]}]},{"name":"Technology and Innovation Commission of Shenzhen Municipality","award":["JCYJ20200109140623124"],"award-info":[{"award-number":["JCYJ20200109140623124"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Preimplantation genetic testing for monogenic disorders (PGT-M) has been used for over 20 years to detect many serious genetic conditions. However, there is still a lack of reference materials (RMs) to validate the test performance during the development and quality control of PGT-M.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Sixteen thalassemia cell lines from four thalassemia families were selected to establish the RMs. Each family consisted of parents with heterozygous mutations for \u03b1- and\/or \u03b2-thalassemia and two children, at least one of whom carried a homozygous thalassemia mutation (proband). The RM panel consisted of 12 DNA samples (parents and probands in 4 families) and 4 simulated embryos (cell lines constructed from blood samples from the four nonproband children). Four accredited genetics laboratories that offer verification of thalassemia samples were invited to evaluate the performance of the RM panel. Furthermore, the stability of the RMs was determined by testing after freeze\u2012thaw cycles and long-term storage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PGT-M reference materials containing 12 genome DNA (gDNA) reference materials and 4 simulated embryo reference materials for thalassemia testing were successfully established. Next-generation sequencing was performed on the samples. The genotypes and haplotypes of all 16 PGT-M reference materials were concordant across the four labs, which used various testing workflows. These well-characterized PGT-M reference materials retained their stability even after 3 years of storage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The establishment of PGT-M reference materials for thalassemia will help with the standardization and accuracy of PGT-M in clinical use.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-024-01803-z","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T15:02:51Z","timestamp":1706022171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of preimplantation genetic testing for monogenic reference materials using next-generation sequencing"],"prefix":"10.1186","volume":"17","author":[{"given":"Weihua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runsi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoufang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"issue":"3","key":"1803_CR1","first-page":"272","volume":"105","author":"DC Baird","year":"2022","unstructured":"Baird DC, Batten SH, Sparks SK. Alpha- and Beta-thalassemia: Rapid evidence review. Am Fam Physician. 2022;105(3):272\u201380.","journal-title":"Am Fam Physician"},{"key":"1803_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2010.05546.x","volume":"1202","author":"DJ Weatherall","year":"2010","unstructured":"Weatherall DJ. Thalassemia as a global health problem: recent progress toward its control in the developing countries. Ann N Y Acad Sci. 2010;1202:17\u201323.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1803_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/jcp.2003.014456","volume":"57","author":"XM Xu","year":"2004","unstructured":"Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, Lu JP, Jia SQ, Xiao GF, Shen X, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517\u201322.","journal-title":"J Clin Pathol"},{"key":"1803_CR4","doi-asserted-by":"publisher","first-page":"101074","DOI":"10.1016\/j.blre.2023.101074","volume":"60","author":"WD Wang","year":"2023","unstructured":"Wang WD, Hu F, Zhou DH, Gale RP, Lai YR, Yao HX, Li C, Wu BY, Chen Z, Fang JP, et al. Thalassaemia in China. Blood Rev. 2023;60:101074.","journal-title":"Blood Rev"},{"issue":"1","key":"1803_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ogc.2017.10.009","volume":"45","author":"C Sullivan-Pyke","year":"2018","unstructured":"Sullivan-Pyke C, Dokras A. Preimplantation genetic screening and preimplantation genetic diagnosis. Obstet Gynecol Clin North Am. 2018;45(1):113\u201325.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"5","key":"1803_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1023\/A:1022571822585","volume":"15","author":"A Kuliev","year":"1998","unstructured":"Kuliev A, Rechitsky S, Verlinsky O, Ivakhnenko V, Evsikov S, Wolf G, Angastiniotis M, Georghiou D, Kukharenko V, Strom C, et al. Preimplantation diagnosis of thalassemias. J Assist Reprod Genet. 1998;15(5):219\u201325.","journal-title":"J Assist Reprod Genet"},{"key":"1803_CR7","doi-asserted-by":"publisher","first-page":"793821","DOI":"10.3389\/fendo.2021.793821","volume":"12","author":"Z Ou","year":"2021","unstructured":"Ou Z, Deng Y, Liang Y, Chen Z, Sun L. Improved non-invasive preimplantation genetic testing for Beta-Thalassemia using spent embryo culture medium containing blastocoelic fluid. Front Endocrinol (Lausanne). 2021;12:793821.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1803_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10815-011-9641-6","volume":"29","author":"W Piyamongkol","year":"2012","unstructured":"Piyamongkol W, Vutyavanich T, Sanguansermsri T. Preimplantation genetic diagnosis of alpha-thalassemia-SEA using novel multiplex fluorescent PCR. J Assist Reprod Genet. 2012;29(1):95\u2013102.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"1803_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tjog.2017.03.002","volume":"56","author":"TH Lee","year":"2017","unstructured":"Lee TH, Hsu YC, Chang CL. Detection of SEA-type \u03b1-thalassemia in embryo biopsies by digital PCR. Taiwan J Obstet Gynecol. 2017;56(4):487\u201394.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"10","key":"1803_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10815-011-9598-5","volume":"28","author":"X Shen","year":"2011","unstructured":"Shen X, Xu Y, Zhong Y, Zhou C, Zeng Y, Zhuang G, Ding C, Li T. Preimplantation genetic diagnosis for \u03b1-and \u03b2-double thalassemia. J Assist Reprod Genet. 2011;28(10):957\u201364.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"1803_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s10038-018-0411-5","volume":"63","author":"F He","year":"2018","unstructured":"He F, Zhou W, Cai R, Yan T, Xu X. Systematic assessment of the performance of whole-genome amplification for SNP\/CNV detection and \u03b2-thalassemia genotyping. J Hum Genet. 2018;63(4):407\u201316.","journal-title":"J Hum Genet"},{"issue":"6","key":"1803_CR12","first-page":"852","volume":"45","author":"XT Shen","year":"2013","unstructured":"Shen XT, Xu YW, Zhong YP, Zeng YH, Wang J, Ding CH, Xing WJ, Zhou CQ. [Combination of multiple displacement amplification with short tandem repeat polymorphismin preimplantation genetic diagnosis]. Beijing Da Xue Xue Bao Yi Xue Ban. 2013;45(6):852\u20138.","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"issue":"3","key":"1803_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/19396368.2017.1296501","volume":"63","author":"L Chen","year":"2017","unstructured":"Chen L, Diao Z, Xu Z, Zhou J, Yan G, Sun H. The clinical application of NGS-based SNP haplotyping for PGD of Hb H disease. Syst Biol Reprod Med. 2017;63(3):212\u20137.","journal-title":"Syst Biol Reprod Med"},{"issue":"2","key":"1803_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/19396368.2020.1832158","volume":"67","author":"D Chen","year":"2021","unstructured":"Chen D, Shen X, Xu Y, Ding C, Ye Q, Zhong Y, Xu Y, Zhou C. Successful four-factor preimplantation genetic testing: \u03b1- and \u03b2-thalassemia, human leukocyte antigen typing, and aneuploidy screening. Syst Biol Reprod Med. 2021;67(2):151\u20139.","journal-title":"Syst Biol Reprod Med"},{"issue":"3","key":"1803_CR15","doi-asserted-by":"publisher","first-page":"hoaa018","DOI":"10.1093\/hropen\/hoaa018","volume":"2020","author":"F Carvalho","year":"2020","unstructured":"Carvalho F, Moutou C, Dimitriadou E, Dreesen J, Gim\u00e9nez C, Goossens V, Kakourou G, Vermeulen N, Zuccarello D, De Rycke M. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders. Hum Reprod Open. 2020;2020(3):hoaa018.","journal-title":"Hum Reprod Open"},{"issue":"8","key":"1803_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/01.GIM.0000183043.94406.81","volume":"7","author":"B Chen","year":"2005","unstructured":"Chen B, CD OC, Boone DJ, Amos JA, Beck JC, Chan MM, Farkas DH, Lebo RV, Richards CS, Roa BB, et al. Developing a sustainable process to provide quality control materials for genetic testing. Genet Med. 2005;7(8):534\u201349.","journal-title":"Genet Med"},{"issue":"4","key":"1803_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1525-1578(10)60478-3","volume":"5","author":"SH Bernacki","year":"2003","unstructured":"Bernacki SH, Stankovic AK, Williams LO, Beck JC, Herndon JE, Snow-Bailey K, Prior TW, Matteson KJ, Wasserman LM, Cole EC, et al. Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing. J Mol Diagn. 2003;5(4):227\u201330.","journal-title":"J Mol Diagn"},{"issue":"2","key":"1803_CR18","doi-asserted-by":"publisher","first-page":"e89855","DOI":"10.1371\/journal.pone.0089855","volume":"9","author":"A Yin","year":"2014","unstructured":"Yin A, Li B, Luo M, Xu L, Wu L, Zhang L, Ma Y, Chen T, Gao S, Liang J, et al. The prevalence and molecular spectrum of \u03b1- and \u03b2-globin gene mutations in 14,332 families of Guangdong Province, China. PLoS ONE. 2014;9(2):e89855.","journal-title":"PLoS ONE"},{"issue":"3","key":"1803_CR19","doi-asserted-by":"publisher","first-page":"e24260","DOI":"10.1002\/jcla.24260","volume":"36","author":"M Wang","year":"2022","unstructured":"Wang M, Zhang X, Zhao Y, Lu Z, Xiao M. Prevalence and genetic analysis of thalassemia in childbearing age population of Hainan, the Free Trade Island in Southern China. J Clin Lab Anal. 2022;36(3):e24260.","journal-title":"J Clin Lab Anal"},{"key":"1803_CR20","doi-asserted-by":"crossref","unstructured":"Volozonoka L, Miskova A, Gailite L. Whole genome amplification in preimplantation genetic testing in the era of massively parallel sequencing. Int J Mol Sci 2022, 23(9).","DOI":"10.3390\/ijms23094819"},{"issue":"4","key":"1803_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/pd.1667","volume":"27","author":"S Coskun","year":"2007","unstructured":"Coskun S, Alsmadi O. Whole genome amplification from a single cell: a new era for preimplantation genetic diagnosis. Prenat Diagn. 2007;27(4):297\u2013302.","journal-title":"Prenat Diagn"},{"issue":"4","key":"1803_CR22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1038\/nprot.2006.326","volume":"1","author":"C Spits","year":"2006","unstructured":"Spits C, Le Caignec C, De Rycke M, Van Haute L, Van Steirteghem A, Liebaers I, Sermon K. Whole-genome multiple displacement amplification from single cells. Nat Protoc. 2006;1(4):1965\u201370.","journal-title":"Nat Protoc"},{"issue":"6114","key":"1803_CR23","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1126\/science.1229164","volume":"338","author":"C Zong","year":"2012","unstructured":"Zong C, Lu S, Chapman AR, Xie XS. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science. 2012;338(6114):1622\u20136.","journal-title":"Science"},{"issue":"4","key":"1803_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.rbmo.2010.01.006","volume":"20","author":"P Renwick","year":"2010","unstructured":"Renwick P, Trussler J, Lashwood A, Braude P, Ogilvie CM. Preimplantation genetic haplotyping: 127 diagnostic cycles demonstrating a robust, efficient alternative to direct mutation testing on single cells. Reprod Biomed Online. 2010;20(4):470\u20136.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"1803_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jmg.2009.069971","volume":"47","author":"AH Handyside","year":"2010","unstructured":"Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, Griffin DK. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47(10):651\u20138.","journal-title":"J Med Genet"},{"issue":"52","key":"1803_CR26","doi-asserted-by":"publisher","first-page":"15964","DOI":"10.1073\/pnas.1523297113","volume":"112","author":"L Yan","year":"2015","unstructured":"Yan L, Huang L, Xu L, Huang J, Ma F, Zhu X, Tang Y, Liu M, Lian Y, Liu P, et al. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses. Proc Natl Acad Sci U S A. 2015;112(52):15964\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1803_CR27","first-page":"4296","volume":"15","author":"Y Hao","year":"2018","unstructured":"Hao Y, Chen D, Zhang Z, Zhou P, Cao Y, Wei Z, Xu X, Chen B, Zou W, Lv M, et al. Successful preimplantation genetic diagnosis by targeted next-generation sequencing on an ion torrent personal genome machine platform. Oncol Lett. 2018;15(4):4296\u2013302.","journal-title":"Oncol Lett"},{"issue":"3","key":"1803_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/19396368.2019.1590479","volume":"65","author":"X Ji","year":"2019","unstructured":"Ji X, Zhang Z, Shi J, He B. Clinical application of NGS-based SNP haplotyping for the preimplantation genetic diagnosis of primary open angle glaucoma. Syst Biol Reprod Med. 2019;65(3):258\u201363.","journal-title":"Syst Biol Reprod Med"},{"issue":"1","key":"1803_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/03630269.2010.547429","volume":"35","author":"CG Zheng","year":"2011","unstructured":"Zheng CG, Liu M, Du J, Chen K, Yang Y, Yang Z. Molecular spectrum of \u03b1- and \u03b2-globin gene mutations detected in the population of Guangxi Zhuang Autonomous Region, people\u2019s Republic of China. Hemoglobin. 2011;35(1):28\u201339.","journal-title":"Hemoglobin"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01803-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-024-01803-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01803-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T15:07:38Z","timestamp":1706022458000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-024-01803-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1803"],"URL":"https:\/\/doi.org\/10.1186\/s12920-024-01803-z","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by MGI\u2019s institutional review board on bioethics (approval no. BGI-IRB 19124-T1) and the Ethics Committee of The Second People\u2019s Hospital of Shenzhen (approval no. KS20190418004-FS2019052003). All recruited members with \u03b1- and\/or \u03b2- thalassemia mutant genotypes signed an informed consent form and agreed to donate whole blood for B lymphoblast cell line development.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Y.S. and S.X. are employed by BGI; B.L. is employed by Basecare Medical Device Co., Ltd.; J.F. is employed by Peking Jabrehoo Med Tech Co., Ltd.; and F.G. was employed by Yikon Genomics Company, Ltd. All authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"33"}}